Vision Innovation Partners Names Chris Moore as CEO

Updated on October 29, 2023

Vision Innovation Partners (“VIP”), a leading Mid-Atlantic eye care platform with nearly 70 locations, today announced the promotion of existing board member and current President, Chris Moore, to Chief Executive Officer, as part of a planned transition in the senior leadership of the company. Former CEO and founder Mike Dunn is now serving as Executive Vice President of Business Development and Vice Chairman of the Board. VIP is a portfolio company of Gryphon Investors, a leading middle-market private equity firm.

“We are delighted for Chris to become VIP’s new CEO,” said Kevin Blank, Operating Partner in Gryphon’s Healthcare Group. “Chris has deep industry experience and familiarity with VIP’s operations and is well qualified to lead the company as it continues to strengthen its growing network of ophthalmology practices. We also extend our thanks to Mike for his longtime service, and we are pleased to benefit from his continuing contributions as he takes on this new role.”

Mr. Moore is a longtime senior executive and has decades of experience in the vision industry. Before becoming a board member and President of VIP, Mr. Moore was the President at Century Vision Global, a regional ophthalmology services consolidator, and also co-founded Integrity Digital Solutions, an ophthalmology-focused electronic medical records software business, where he served as CEO. Mr. Moore holds a BS from Sam Houston State University and an MBA from the M.J. Neeley School of Business at Texas Christian University.

Luke Schroeder, Partner in Gryphon’s Healthcare Group, said, “Chris has been driving improved delivery of practice management support resources to VIP locations, offering an attractive value proposition to partner physicians. We are confident he is the right person to move VIP forward as the organization continues to scale and expand its footprint through both organic initiatives and additional M&A, which will solidify its position as the partner of choice for ophthalmologists and optometrists in the Mid-Atlantic region.”

Mr. Moore added, “I am excited to lead the team at VIP as we accelerate our growth trajectory and fulfill our commitment to providing excellent support to our eye care professionals.  With the support of Gryphon Investors and the VIP team, I look forward to capitalizing on the opportunities ahead together.”

# # #

About Vision Innovation Partners 

Founded in 2017 and headquartered in Annapolis, MD, VIP supports the mid-Atlantic’s premier ophthalmology practices and surgery centers through good people, expert leadership, the sharing of best practices and the backing of Gryphon Investors, a leading middle-market private equity firm. VIP’s managed practices offer a comprehensive range of services, including routine eye exams and LASIK surgery as well as treatment for cataracts, glaucoma, macular degeneration, and other ocular diseases. The Company is among the region’s leading managed services platforms for ophthalmology providers, with more than 140 practitioners and a footprint that includes nearly 60 practice locations and 11 surgery centers across Maryland, Washington D.C., Virginia, and Pennsylvania.

About Gryphon Investors 

Gryphon Investors ( is a leading middle-market private equity firm focused on profitably growing and competitively advantaged companies in the Business Services, Consumer, Healthcare, Industrial Growth, and Software sectors. With approximately $9 billion of assets under management, Gryphon prioritizes investments in which it can form strong partnerships with founders, owners, and executives to accelerate the building of leading companies and generate enduring value through its integrated deal and operations business model. Gryphon’s highly differentiated model integrates its well-proven Operations Resources Group, which is led by full-time, Gryphon senior operating executives with general management, human capital acquisition and development, treasury, finance, and accounting expertise. Gryphon’s three core investment strategies include its Flagship, Heritage, and Junior Capital strategies, each with dedicated funds of capital. The Flagship and Heritage strategies target equity investments of $50 million to $350 million per portfolio company. The Junior Capital strategy targets investments in junior securities of credit facilities, arranged by leading middle-market lenders, in both Gryphon-controlled companies, as well as in other private equity-backed companies operating in Gryphon’s targeted investment sectors.

The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.